Dear Authors,
If you believe that your paper was mistakenly rejected by other leading journals and you do not agree with final decision, the editors of Reports of Practical Oncology and Radiotherapy offer new fast track review. You may submit your manuscript to Reports of Practical Oncology and Radiotherapy together with all prior peer-reviews obtained from the other journal and your rebuttal letter. We guarantee review based decision within 72 hours from the time we will receive your manuscript.

Fast track submission process: Please submit the manuscript with all reviews and rebuttal letter by email to Dr. Michal Masternak (michal.masternak@ucf.edu) for fast review processing. To assure immediate attention the email title must to include: RPOR-fast track- Last Name First Name (of corresponding author).

Volume 12, Number 3, 2007

Strategies for prevention of infectious complications in children after HSCT in relation to type of transplantation and GVHD occurrence

Jan Styczyński, Lidia Gil

Summary:

<b>Background</b> Infectious complications are a major cause of morbidity and mortality in paediatric and adult patients undergoing haematopoietic stem cell transplantation (HSCT).
<b>Aim</b> Analysis of strategies for prevention of infectious complications in children after
HSCT in relation to the type of transplantation and GVHD occurrence.
<b>Materials/Methods</b> A review of PubMed references based on evidence-based recommendations rated by the strength of the recommendation and the quality of the supporting evidence. The risk of infection was divided into: low for autologous HSCT, moderate for MSD-HSCT without GVHD, and high for unrelated, mismatched, haploidentical
HSCT, cord blood HSCT, patients with moderate-to-severe GVHD, undergoing
immunosuppressive treatment, CMV infection, ex vivo T-cell depletion or
CD34 selection and in vivo T-cell depletion.
<b>Results</b> Prophylaxis strategy includes general infection control in hospital environment and pharmacological approach, related to antibacterial, antifungal and antiviral
agents. Most studies were done on adult patients only, while some included both
paediatric and adults patients. However, no differences in prophylaxis strategy and
efficacy between age groups were reported in these studies. Recommendations
for use of specifi c drugs in prophylaxis in transplantation period and recommendations
for vaccination are presented in this paper.
<b>Conclusions</b> With changing practices, transplant teams are encouraged to review local patterns of infections and associated complications and communicate regularly with infection control committees for guidance on the evolution of isolation needs for the immunosuppressed patient before and after HSCT.

Signature: Rep Pract Oncol Radiother, 2007; 12(3) : 149-157

FULL TXT (PDF: 0,10MB)

« back

 
INDEXED IN:

Indexed in: EMBASE®, the Excerpta Medica database, the Elsevier BIOBASE (Current Awareness in Biological Sciences) and in the Index Copernicus.

http://www.sciencedirect.com/science/journal/15071367/19/2